Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study.

Saved in:
Bibliographic Details
Title: Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study.
Authors: Powderly JD; Cancer Research Clinic, Carolina BioOncology Institute, Huntersville, NC, USA., Klempner SJ; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Naing A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bendell J; Drug Development Unit, Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA., Garrido-Laguna I; Division of Oncology, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, UT, USA., Catenacci DVT; Department of Medicine, University of Chicago, Chicago, IL, USA., Taylor MH; Division of Hematology and Oncology, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Lee JJ; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburg, PA, USA., Zheng F; Incyte Corporation, Wilmington, DE, USA., Zhou F; Incyte Corporation, Wilmington, DE, USA., Gong X; Incyte Corporation, Wilmington, DE, USA., Gowda H; Incyte Corporation, Wilmington, DE, USA., Beatty GL; Department of Medicine, Abramson Cancer Center and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Source: The oncologist [Oncologist] 2022 Nov 03; Vol. 27 (11), pp. 905-e848.
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1549-490X
DOI:10.1093/oncolo/oyac174